Anna
Vilalta Lacarra
Colaboradora Clínica
Publicaciones (8) Publicaciones de Anna Vilalta Lacarra
2024
-
Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD-1/PD-L1 axis blockade via Id1 downregulation
Molecular Cancer, Vol. 23, Núm. 1
2023
-
"What medical students with better academic results do: a cross-sectional analysis"
BMC medical education, Vol. 23, Núm. 1, pp. 19
-
A novel [89Zr]-anti-PD-1-PET-CT to assess response to PD-1/PD-L1 blockade in lung cancer
Frontiers in Immunology, Vol. 14
-
Association of depression phenotypes and antidepressant treatment with mortality due to cancer and other causes: a community-based cohort study
Frontiers in Psychology, Vol. 14
-
Biología celular del cáncer
Biología celular biomédica (Elsevier), pp. 375-407
-
Integration of longitudinal deep-radiomics and clinical data improves the prediction of durable benefits to anti-PD-1/PD-L1 immunotherapy in advanced NSCLC patients
Journal of Translational Medicine, Vol. 21, Núm. 1
-
Therapeutic drug monitoring of neoadjuvant mFOLFIRINOX in resected pancreatic ductal adenocarcinoma
Pancreatology, Vol. 23, Núm. 4, pp. 411-419